Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Emergis Inc. (EME-T-DEAD)

BUY
Funded by BCE so should be safe. Difficult to evaluate. Would buy BCE instead which would give you some ownership.
TOP PICK
Thinks its bee beaten down too far. Has a great business model.
DON'T BUY
Fair Market Value = $31. Getting to a cheap level, but could drop to $19/20.
DON'T BUY
Improving their sales in financial services/health care, but valuation is still too high. Could drop further.
WAIT
The balance sheet is large for the earnings its getting. On a technical basis, if it holds at $24.50 it could go up to $34.
BUY
Great company. Diversifying. Should rebound.
DON'T BUY
Has dropped substantially. Earnings estimates are down.
BUY
There is too much business tied in with their parent, but should expand out to other areas. Has dropped to a good level.
DON'T BUY
Have provided limited guidance. Will take awhile.
DON'T BUY
A very uncertain sector now. BCE may not support in future.
TOP PICK
Good price. Earnings are OK.
DON'T BUY
Higher risk. Prefers First Data or Concord EFS.
TOP PICK
Good contracts with BCE. Lack of guidance dropped the price too far. Good valuation.
TOP PICK
Likes the e-commerce sector. A good price.
DON'T BUY
Fair Market Value is $36/37, so its too rich now.
Showing 76 to 90 of 168 entries